Objectives: To use a large national comparative database to measure the internal effect of a set of evidence-based bronchiolitis/viral pneumonia clinical care guidelines on clinical practice at a children's hospital, and to compare these changes with those at other children's hospitals.

Design: Prospective cohort study with retrospective and concurrent (other hospital) controls.

Setting: The Children's Hospital, Denver, Colo.

Participants: Hospitalized children with bronchiolitis and/or viral pneumonia.

Interventions: Our clinical guidelines focused on clear admission and discharge criteria, individualized transition-anticipating orders, and "prove it or don't use it" criteria for the use of respiratory syncytial virus testing, bronchodilators, chest physiotherapy, and ribavirin.

Main Outcome Measures: The effect of guideline implementation was determined by comparative measurement of internal changes in utilization and outcome (nosocomial infection rate) across time and by external comparison with other children's hospitals using standardized data from the Pediatric Health Information System database of the Child Health Corporation of America (Shawnee Mission, Kan).

Results: Overall, 10 636 bronchiolitis/viral pneumonia cases were studied: 1302 at the index hospital and 9334 at the 7 comparison hospitals. Internally, the index hospital's residents and attending physicians responded favorably to the bronchiolitis/viral pneumonia care guidelines, resulting in decreases in targeted resource utilization. There were no fatalities, and the number of days in the intensive care unit decreased even though the mean severity of admitted cases increased significantly. Targeted utilization was favorably affected, whereas untargeted utilization was not. Nosocomial infections did not increase with a decreased use of respiratory syncytial virus testing. The index hospital differed favorably from other children's hospitals in several categories.

Conclusion: Evidence-based care guidelines can successfully influence utilization and clinical outcome.

Download full-text PDF

Source
http://dx.doi.org/10.1001/archpedi.156.11.1086DOI Listing

Publication Analysis

Top Keywords

bronchiolitis/viral pneumonia
16
care guidelines
12
large national
8
pneumonia clinical
8
clinical care
8
resource utilization
8
children's hospital
8
respiratory syncytial
8
syncytial virus
8
virus testing
8

Similar Publications

Background: Acute lower respiratory tract infection (ALRI) and acute diarrheal disease (ADD) are the leading causes of mortality in children globally. There is emerging evidence of an association between maternal hypovitaminosis D and ALRI/ADD during infancy.

Objective: To determine whether maternal hypovitaminosis D (25(OH)D [<20 ng/ml] during late pregnancy is associated with increased risk of ALRI/ADD in their offspring during infancy.

View Article and Find Full Text PDF

Bronchiolitis: Increased severity in the post-COVID-19 era.

Pediatr Pulmonol

December 2024

Sorbonne Université, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Trousseau, Service de Pneumologie Pédiatrique, Centre de Référence des Maladies Respiratoires Rares RespiRare, Paris, France.

Article Synopsis
  • Acute bronchiolitis is a major public health issue, leading to many infant hospitalizations, with a notable decrease during the COVID-19 pandemic raising concerns about a potential resurgence afterward.
  • A study assessed bronchiolitis severity and viral agents by comparing infant hospitalizations over a 5-year span—two years before COVID, during COVID, and two years after.
  • Findings showed that while hospital admissions were similar pre- and post-COVID, bronchiolitis severity increased post-pandemic, particularly among younger infants with higher rates of RSV infections, underscoring the need for effective preventive measures.
View Article and Find Full Text PDF

SARS-CoV-2 and RSV bronchiolitis outcomes.

Heart Lung

October 2024

University of Texas Medical Branch: Galveston - Department of Emergency Medicine, 301 University Blvd, Galveston, TX 77555-1173, United States.

Background: Severe acute respiratory syndrome related coronavirus (SARS-CoV-2) bronchiolitis has arisen with the SARS-CoV-2 pandemic. There is a paucity of literature on SARS-CoV-2 bronchiolitis.

Objective: The purpose of our paper was to review and compare outcomes in bronchiolitis due to severe acute respiratory syndrome related coronavirus 2 (SARS- CoV-2) and Respiratory Syncytial Virus (RSV).

View Article and Find Full Text PDF

Prevalence of Bacterial Codetection and Outcomes for Infants Intubated for Respiratory Infections.

Pediatr Crit Care Med

July 2024

Red Colaborativa Pediátrica de Latinoamérica (LARed Network), Montevideo, Uruguay.

Article Synopsis
  • The study aimed to find out how common respiratory bacterial codetection is in children under 2 years old who are intubated for acute lower respiratory tract infections, mainly viral bronchiolitis, and to see how it affects the duration of mechanical ventilation.
  • It analyzed 472 children, finding that 29% had bacterial codetection, with younger age and positive RSV tests linked to higher rates, while codetection didn't show a clear connection to longer mechanical ventilation duration.
  • The research suggests that while bacterial codetection is common, it may not significantly impact the length of time patients need invasive mechanical ventilation.
View Article and Find Full Text PDF

Background: Our aim was to hypothesize that the COVID-19 pandemic influenced the characteristics of viral bronchiolitis by comparing the last 3 epidemics with 3 pre-COVID-19 epidemics in infants hospitalized with bronchiolitis.

Methods: We prospectively enrolled 637 consecutive infants (median age 3.0 ± 2.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!